Symposium 2021 Posters Meaningful progress in the therapy of neuroendocrine cancers, needs rigorous interpretation of data and balanced trial designs Read More » February 7, 2022 No Comments
Symposium 2021 Posters Gold Coated Nanoparticles as a vehicle for 225Ac/89Zr delivery for use as a Theragnostic Agent in Targeted a-Therapy Read More » February 7, 2022 No Comments
Symposium 2021 Posters The Wnt signaling protein Dishevelled targets Somatostatin Receptor 2 for lysosomal degradation Read More » February 7, 2022 No Comments
Symposium 2021 Posters Drug Combinations to Harness Metabolic Stress in the Therapy of Neuroendocrine Tumors Read More » February 7, 2022 No Comments
Symposium 2021 Posters Generating neuroendocrine tumor models to build a disease specific dependency map Read More » February 7, 2022 No Comments
Symposium 2021 Posters The Impact of Microbiome on Diagnostic and Therapeutic Theranostics in Gastroentero-pancreatic Neuroendocrine Tumors (GEP-NETs) Read More » February 7, 2022 No Comments
Symposium 2021 Posters International survey on opinions and use of minimally invasive surgery for small bowel neuroendocrine neoplasms Read More » February 7, 2022 No Comments
Symposium 2021 Posters Mesenteric fibrosis in small intestinal neuroendocrine tumors Read More » February 7, 2022 No Comments
Symposium 2021 Posters Long term follow-up of patients with Small Intestine Neuroendocrine Tumors submitted to Ex Vivo Beta- Radioguided Surgery with Y-90-DOTATOC Read More » February 7, 2022 No Comments
Symposium 2021 Posters Inhibition of serotonin biosynthesis suppresses tumor growth in vivo Read More » February 7, 2022 No Comments
